<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="endocrine disorders who develop COVID-19, several factors warrant management decisions." exact="Hydrocortisone" post="dose adjustments are required in patients with adrenal insufficiency."/>
 <result pre="be associated with postviral hypocortisolism and are dramatically improved with" exact="cortisol" post="replacement [41]. Furthermore, insertion/deletion polymorphisms in the ACE gene"/>
 <result pre="[52] Hypernatremia Impaired level of consciousness Monitor electrolytes Replacement Convert" exact="desmopressin" post="to parenteral form [52] Hypokalemia Gastrointestinal losses [52] Upregulation"/>
 <result pre="Persistently low blood pressure Hyperkalemia and hyponatremia Serum 9 am" exact="cortisol" post="Cosyntropin test Hydrocortisone therapy Thyroid Hypothyroidism Destruction of follicular"/>
 <result pre="low blood pressure Hyperkalemia and hyponatremia Serum 9 am cortisol" exact="Cosyntropin" post="test Hydrocortisone therapy Thyroid Hypothyroidism Destruction of follicular and"/>
 <result pre="pressure Hyperkalemia and hyponatremia Serum 9 am cortisol Cosyntropin test" exact="Hydrocortisone" post="therapy Thyroid Hypothyroidism Destruction of follicular and parafollicular cells"/>
 <result pre="regarding possible electrolyte imbalances and should titrate any corticosteroid or" exact="desmopressin" post="doses accordingly. If intranasal desmopressin cannot be administered because"/>
 <result pre="should titrate any corticosteroid or desmopressin doses accordingly. If intranasal" exact="desmopressin" post="cannot be administered because of impaired consciousness, it can"/>
 <result pre="COVID-19 Endocrine Condition Management Diabetes insipidus Titrate the dose of" exact="desmopressin" post="according to serum sodium, and osmolality. Convert to parenteral"/>
 <result pre="parenteral form (IV/IM) if intranasal route is not feasible [52]" exact="Desmopressin" post="dose equivalents [138] Tablets Spray Injections 100 Âµg 2.5"/>
 <result pre="established GH deficiency [58] Hypoadrenalism Double the morning dose of" exact="hydrocortisone" post="and continue 20 mg 4 times daily, or give"/>
 <result pre="continue 20 mg 4 times daily, or give doubled usual" exact="hydrocortisone" post="dose (â€œsick day ruleâ€�), depending on the infection severity"/>
 <result pre="patient characteristics [64] During an adrenal crisis, IM or IV" exact="hydrocortisone" post="100 mg stat followed by 200 mg over 24-hour"/>
 <result pre="infusion [66] Patients with primary hypoadrenalism do not require increasing" exact="fludrocortisone" post="dose [65] Critical illness-related corticosteroid insufficiency (CIRCI): IV hydrocortisone"/>
 <result pre="increasing fludrocortisone dose [65] Critical illness-related corticosteroid insufficiency (CIRCI): IV" exact="hydrocortisone" post="400 mg daily for 3 days or longer depending"/>
 <result pre="syndrome Continue medical management in those with active disease IV" exact="etomidate" post="at a rate of 0.04 to 0.05 mg/kg/h for"/>
 <result pre="to 0.05 mg/kg/h for those with severe illness targeting a" exact="cortisol" post="level 500-800 nmol/L [78, 79] Anticoagulation to be considered"/>
 <result pre="hypocalcemia increases the risk of QT prolongation with chloroquine/hydroxychloroquine and" exact="azithromycin" post="[112] Vitamin D deficiency Vitamin D supplements to achieve"/>
 <result pre="10 000 IU depending on the requirement [131, 132] Hypogonadism" exact="Testosterone" post="Temporary discontinuation may be possible if medication is not"/>
 <result pre="changing to an alternative is possible (e.g., intramuscular injections to" exact="testosterone" post="gel) Estrogen Conversion to transdermal formulations when applicable as"/>
 <result pre="an alternative is possible (e.g., intramuscular injections to testosterone gel)" exact="Estrogen" post="Conversion to transdermal formulations when applicable as the thrombosis"/>
 <result pre="the thrombosis risk is lower with transdermal compared to oral" exact="estrogen" post="Based on the currently available evidence, patients with preexisting"/>
 <result pre="the currently available evidence, patients with preexisting hyperprolactinemia may continue" exact="dopamine" post="receptor agonist (DRA) therapy during the pandemic and during"/>
 <result pre="the clinical significance of higher plasma bromocriptine levels is uncertain." exact="Cabergoline" post="is less affected by such enzyme modulations because only"/>
 <result pre="temporary discontinuation of DRAs in severe COVID-19 should be considered." exact="Chloroquine" post="is not known to adversely interact with DRAs. In"/>
 <result pre="cell apoptosis in pituitary tumors when used in combination with" exact="cabergoline" post="in animal studies [57]. However, these beneficial effects are"/>
 <result pre="would be on steroid replacement in physiological doses, usually with" exact="hydrocortisone" post="which needs continuation without disruption. Patients should have a"/>
 <result pre="have a â€œsteroid emergency cardâ€� and bracelet with details of" exact="hydrocortisone" post="dosing during an infection. Standard guidelines suggest doubling the"/>
 <result pre="continuous inflammation [63, 64]. Therefore, an immediate dose of doubled" exact="hydrocortisone" post="morning dose, followed by replacement dose of 20 mg"/>
 <result pre="features of acute adrenal insufficiency would warrant IV or IM" exact="hydrocortisone" post="treatment with 100 mg given immediately, followed by 200"/>
 <result pre="[66]. Patients with primary adrenal insufficiency would not require additional" exact="fludrocortisone" post="in this setting as hydrocortisone doses above 50 mg"/>
 <result pre="insufficiency would not require additional fludrocortisone in this setting as" exact="hydrocortisone" post="doses above 50 mg per day are known to"/>
 <result pre="and improve the outcomes in these patients. The decision on" exact="hydrocortisone" post="treatment and the appropriate dose can be guided by"/>
 <result pre="treatment and the appropriate dose can be guided by baseline" exact="cortisol" post="level, and the target level expected in severely ill"/>
 <result pre="or sepsis, this response may be inadequate because of impaired" exact="cortisol" post="secretion or cortisol resistance caused by abnormalities in glucocorticoid"/>
 <result pre="response may be inadequate because of impaired cortisol secretion or" exact="cortisol" post="resistance caused by abnormalities in glucocorticoid receptors, known as"/>
 <result pre="[69, 70]. Based on the available evidence, a random serum" exact="cortisol" post="of less than 275 nmol/L (10 Âµg/dL) or a"/>
 <result pre="of less than 275 nmol/L (10 Âµg/dL) or a serum" exact="cortisol" post="rise by less than 248 nmol/L (9 Âµg/dL) at"/>
 <result pre="Furthermore, one needs to be aware that threshold levels of" exact="cortisol" post="will vary according to assay. These assay-related variations can"/>
 <result pre="ill patients because of the presence of heterophile antibodies and" exact="cortisol" post="metabolites, and can impact the diagnosis of CIRCI [69,"/>
 <result pre="can be considered based on clinical parameters, regardless of the" exact="cortisol" post="response, following a discussion between the treating intensivist and"/>
 <result pre="and endocrinologist. Patients with CIRCI can be treated with IV" exact="hydrocortisone" post="(up to 400 mg/day) for 3 days or longer"/>
 <result pre="once the patientâ€™s condition is stable [70]. The decision regarding" exact="hydrocortisone" post="treatment should be made cautiously, and it is also"/>
 <result pre="to be mindful about the possible drug interactions as well." exact="Ritonavir" post="is known to inhibit the cytochrome P4503A enzyme and"/>
 <result pre="settles and they are stable to undergo definitive therapy. Intravenous" exact="etomidate" post="can be considered in patients with severe illness needing"/>
 <result pre="glucocorticoid-lowering therapy with careful dose adjustments to achieve a target" exact="cortisol" post="level. If the patient has coexisting acute kidney injury,"/>
 <result pre="If nonthyroidal illness syndrome is suspected, therapy with thyroxine or" exact="liothyronine" post="is not currently recommended because of lack of clinical"/>
 <result pre="on immunosuppressants [90]. However, patients who are on glucocorticoids and" exact="mycophenolate mofetil" post="for thyroid eye disease should especially adhere to social"/>
 <result pre="is advisable. There might be difficulty in accessing medications including" exact="testosterone" post="injections. It may be reasonable to postpone replacement in"/>
 <result pre="substitution of the alternative dosage forms is an option. If" exact="testosterone" post="gel preparation is substituted for injections, the gel can"/>
 <result pre="can be commenced from the due date of the next" exact="testosterone" post="injection [58]. In the case of female hormone replacement,"/>
 <result pre="critical illness-related corticosteroid insufficiency COVID-19 coronavirus-19 CS Cushing syndrome DRA" exact="dopamine" post="receptor agonist FGF2 fibroblast growth factor 2 HPA hypothalamo-pituitary-adrenal"/>
 <result pre="Metab.2018;62(2):236-263.29768629 49.VardasK, ApostolouK, BriassouliE, et al.Early response roles for prolactin" exact="cortisol" post="and circulating and cellular levels of heat shock proteins"/>
 <result pre="57.LinSJ, WuZR, CaoL, et al.Pituitary tumor suppression by combination of" exact="cabergoline" post="and chloroquine. J Clin Endocrinol Metab.2017;102(10):3692-3703.28973192 58.COVID-19 resources for"/>
 <result pre="Endocr Connect.2016;5(5):G1-G3.27935813 63.PreteA, TaylorAE, BancosI, et al.Prevention of adrenal crisis:" exact="cortisol" post="responses to major stress compared to stress dose hydrocortisone"/>
 <result pre="crisis: cortisol responses to major stress compared to stress dose" exact="hydrocortisone" post="delivery. J Clin Endocrinol Metab. 2020;105(7). doi:10.1210/clinem/dgaa133 64.ArltW, BaldewegSE,"/>
 <result pre="2017. Crit Care Med.2017;45(12):2078-2088.28938253 71.CohenJ, WardG, PrinsJ, JonesM, VenkateshBVariability of" exact="cortisol" post="assays can confound the diagnosis of adrenal insufficiency in"/>
 <result pre="McKiernanFIatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with" exact="ritonavir" post="and fluticasone. Springerplus.2015;4:455.26322261 73.PivonelloR, FerrignoR, IsidoriAM, BillerBMK, GrossmanAB, ColaoACovid-19"/>
 <result pre="al.Self-care for common colds: the pivotal role of vitamin D," exact="vitamin C," post="ainc, and echinacea in three main immune interactive clusters"/>
 <result pre="Clin Nutr. 2020. doi:10.1038/s41430-020-0558-y 133.HeaneyRP, DaviesKM, ChenTC, HolickMF, Barger-LuxMJHuman serum" exact="25-hydroxycholecalciferol" post="response to extended oral dosing with cholecalciferol. Am J"/>
</results>
